First, methodologies for the detection of serum tumor markers (AFP, AFP-L3% and PIVKA-II) and laboratory tests (TBIL, ALB and PLT) vary by clinical settings, so the observed efficacy of serum tumor markers and diagnostic models may be different from those in this study. Here, AFP is linked to neoplasm.